Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate
•Stable Jurkat cell line expressing AID-His130Pro was established.•Mutagenic activity of AID-His130Pro mutant was assessed on an artificial substrate.•AID-His130Pro retained a significant mutagenic activity.•The His130 residue is located in a region required for CSR but not for SHM. Activation induc...
Gespeichert in:
Veröffentlicht in: | Molecular immunology 2016-11, Vol.79, p.77-82 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 82 |
---|---|
container_issue | |
container_start_page | 77 |
container_title | Molecular immunology |
container_volume | 79 |
creator | Ouadani, Hanen Ben-Mustapha, Imen Ben-ali, Meriem Larguèche, Beya Jovanic, Tihana Garcia, Sylvie Arcangioli, Benoit Elloumi-Zghal, Houda Fathallah, Dahmani Hachicha, Mongia Masmoudi, Hatem Rougeon, François Barbouche, Mohamed-Ridha |
description | •Stable Jurkat cell line expressing AID-His130Pro was established.•Mutagenic activity of AID-His130Pro mutant was assessed on an artificial substrate.•AID-His130Pro retained a significant mutagenic activity.•The His130 residue is located in a region required for CSR but not for SHM.
Activation induced cytidine deaminase (AID) is an essential enzyme for class switch recombination (CSR) and somatic hypermutation (SHM) during secondary immune response. Mutations in the AICDA gene are responsible for Hyper IgM 2 syndrome where both CSR and SHM or only CSR are affected. Indeed, triggering either of the two mechanisms requires the DNA deamination activity of AID. Besides, different domains of AID may be differentially involved in CSR and SHM through their interaction with specific cofactors. Herein, we studied the AID-induced SHM activity of the AID-His130Pro mutant identified in a patient with Hyper IgM 2 syndrome. AID mutagenic activity was monitored by the reversion of nonsense mutations of the EGFP gene assessed by flow cytometry. We found that the His130Pro mutation, which affects CSR, preserves AID mutagenic activity. Indeed, the His130 residue is located in a putative specific CSR region in the APOBEC-like domain, known to involve CSR specific cofactors that probably play a major role in AID physiological activities. |
doi_str_mv | 10.1016/j.molimm.2016.09.025 |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_pasteur_01453058v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161589016302061</els_id><sourcerecordid>1835390707</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-95100d1d19464d85b5c48e4f8765bc60daef1035db9b348b2929e37d62f530353</originalsourceid><addsrcrecordid>eNp9kc1u1DAURi0EokPhDRDysiwSbMdO4g3SqBQy0lRUKqwtx74pHuUP2xlpHoJ3roeULllZts_9PukehN5TklNCy0-HfJh6Nww5S7ecyJww8QJtaF2xTFLOXqJN-qCZqCW5QG9COBBCSlKK1-iCVRUtBRMb9Gdrojvq6KYRu9EuBiw2p-isGwFb0IMbdQA8LFGPEV9td1-yxgVakDs_fcSdnwbcnGbwePdwixmeUxIk0EPUKcH-HXyA0Rmsz0UunnBqum9usfbRdc443eOwtCF6HeEtetXpPsC7p_MS_fx68-O6yfbfv-2ut_vMcF7GTApKiKWWSl5yW4tWGF4D7-qqFK0pidXQUVII28q24HXLJJNQVLZknSjSe3GJsjX3l-7V7N2g_UlN2qlmu1ezDhEWrwjliRb1kSb-auVnP_1eIEQ1uGCg7_UI0xIUrVOoJBWpEspX1PgpBA_dcz4l6ixOHdQqTp3FKSJVEpfGPjw1LO0A9nnon6kEfF4BSHs5OvAqmLTq5Mt5MFHZyf2_4RGVO6tL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835390707</pqid></control><display><type>article</type><title>Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ouadani, Hanen ; Ben-Mustapha, Imen ; Ben-ali, Meriem ; Larguèche, Beya ; Jovanic, Tihana ; Garcia, Sylvie ; Arcangioli, Benoit ; Elloumi-Zghal, Houda ; Fathallah, Dahmani ; Hachicha, Mongia ; Masmoudi, Hatem ; Rougeon, François ; Barbouche, Mohamed-Ridha</creator><creatorcontrib>Ouadani, Hanen ; Ben-Mustapha, Imen ; Ben-ali, Meriem ; Larguèche, Beya ; Jovanic, Tihana ; Garcia, Sylvie ; Arcangioli, Benoit ; Elloumi-Zghal, Houda ; Fathallah, Dahmani ; Hachicha, Mongia ; Masmoudi, Hatem ; Rougeon, François ; Barbouche, Mohamed-Ridha</creatorcontrib><description>•Stable Jurkat cell line expressing AID-His130Pro was established.•Mutagenic activity of AID-His130Pro mutant was assessed on an artificial substrate.•AID-His130Pro retained a significant mutagenic activity.•The His130 residue is located in a region required for CSR but not for SHM.
Activation induced cytidine deaminase (AID) is an essential enzyme for class switch recombination (CSR) and somatic hypermutation (SHM) during secondary immune response. Mutations in the AICDA gene are responsible for Hyper IgM 2 syndrome where both CSR and SHM or only CSR are affected. Indeed, triggering either of the two mechanisms requires the DNA deamination activity of AID. Besides, different domains of AID may be differentially involved in CSR and SHM through their interaction with specific cofactors. Herein, we studied the AID-induced SHM activity of the AID-His130Pro mutant identified in a patient with Hyper IgM 2 syndrome. AID mutagenic activity was monitored by the reversion of nonsense mutations of the EGFP gene assessed by flow cytometry. We found that the His130Pro mutation, which affects CSR, preserves AID mutagenic activity. Indeed, the His130 residue is located in a putative specific CSR region in the APOBEC-like domain, known to involve CSR specific cofactors that probably play a major role in AID physiological activities.</description><identifier>ISSN: 0161-5890</identifier><identifier>EISSN: 1872-9142</identifier><identifier>DOI: 10.1016/j.molimm.2016.09.025</identifier><identifier>PMID: 27716525</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Activation induced cytidine deaminase ; AID mutagenic activity ; Blotting, Western ; Class switch recombination ; Cofactors ; Cytidine Deaminase ; Cytidine Deaminase - genetics ; Humans ; Hyper IgM 2 ; Hyper-IgM Immunodeficiency Syndrome ; Hyper-IgM Immunodeficiency Syndrome - genetics ; Immunoglobulin Class Switching ; Immunoglobulin Class Switching - genetics ; Jurkat Cells ; Life Sciences ; Mutagenesis, Site-Directed ; Mutation ; Somatic hypermutation ; Somatic Hypermutation, Immunoglobulin ; Somatic Hypermutation, Immunoglobulin - genetics</subject><ispartof>Molecular immunology, 2016-11, Vol.79, p.77-82</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><rights>Attribution</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-95100d1d19464d85b5c48e4f8765bc60daef1035db9b348b2929e37d62f530353</citedby><cites>FETCH-LOGICAL-c446t-95100d1d19464d85b5c48e4f8765bc60daef1035db9b348b2929e37d62f530353</cites><orcidid>0000-0002-0525-8620 ; 0000-0002-1371-1405 ; 0000-0002-7655-8911</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.molimm.2016.09.025$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27716525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://riip.hal.science/pasteur-01453058$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Ouadani, Hanen</creatorcontrib><creatorcontrib>Ben-Mustapha, Imen</creatorcontrib><creatorcontrib>Ben-ali, Meriem</creatorcontrib><creatorcontrib>Larguèche, Beya</creatorcontrib><creatorcontrib>Jovanic, Tihana</creatorcontrib><creatorcontrib>Garcia, Sylvie</creatorcontrib><creatorcontrib>Arcangioli, Benoit</creatorcontrib><creatorcontrib>Elloumi-Zghal, Houda</creatorcontrib><creatorcontrib>Fathallah, Dahmani</creatorcontrib><creatorcontrib>Hachicha, Mongia</creatorcontrib><creatorcontrib>Masmoudi, Hatem</creatorcontrib><creatorcontrib>Rougeon, François</creatorcontrib><creatorcontrib>Barbouche, Mohamed-Ridha</creatorcontrib><title>Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate</title><title>Molecular immunology</title><addtitle>Mol Immunol</addtitle><description>•Stable Jurkat cell line expressing AID-His130Pro was established.•Mutagenic activity of AID-His130Pro mutant was assessed on an artificial substrate.•AID-His130Pro retained a significant mutagenic activity.•The His130 residue is located in a region required for CSR but not for SHM.
Activation induced cytidine deaminase (AID) is an essential enzyme for class switch recombination (CSR) and somatic hypermutation (SHM) during secondary immune response. Mutations in the AICDA gene are responsible for Hyper IgM 2 syndrome where both CSR and SHM or only CSR are affected. Indeed, triggering either of the two mechanisms requires the DNA deamination activity of AID. Besides, different domains of AID may be differentially involved in CSR and SHM through their interaction with specific cofactors. Herein, we studied the AID-induced SHM activity of the AID-His130Pro mutant identified in a patient with Hyper IgM 2 syndrome. AID mutagenic activity was monitored by the reversion of nonsense mutations of the EGFP gene assessed by flow cytometry. We found that the His130Pro mutation, which affects CSR, preserves AID mutagenic activity. Indeed, the His130 residue is located in a putative specific CSR region in the APOBEC-like domain, known to involve CSR specific cofactors that probably play a major role in AID physiological activities.</description><subject>Activation induced cytidine deaminase</subject><subject>AID mutagenic activity</subject><subject>Blotting, Western</subject><subject>Class switch recombination</subject><subject>Cofactors</subject><subject>Cytidine Deaminase</subject><subject>Cytidine Deaminase - genetics</subject><subject>Humans</subject><subject>Hyper IgM 2</subject><subject>Hyper-IgM Immunodeficiency Syndrome</subject><subject>Hyper-IgM Immunodeficiency Syndrome - genetics</subject><subject>Immunoglobulin Class Switching</subject><subject>Immunoglobulin Class Switching - genetics</subject><subject>Jurkat Cells</subject><subject>Life Sciences</subject><subject>Mutagenesis, Site-Directed</subject><subject>Mutation</subject><subject>Somatic hypermutation</subject><subject>Somatic Hypermutation, Immunoglobulin</subject><subject>Somatic Hypermutation, Immunoglobulin - genetics</subject><issn>0161-5890</issn><issn>1872-9142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAURi0EokPhDRDysiwSbMdO4g3SqBQy0lRUKqwtx74pHuUP2xlpHoJ3roeULllZts_9PukehN5TklNCy0-HfJh6Nww5S7ecyJww8QJtaF2xTFLOXqJN-qCZqCW5QG9COBBCSlKK1-iCVRUtBRMb9Gdrojvq6KYRu9EuBiw2p-isGwFb0IMbdQA8LFGPEV9td1-yxgVakDs_fcSdnwbcnGbwePdwixmeUxIk0EPUKcH-HXyA0Rmsz0UunnBqum9usfbRdc443eOwtCF6HeEtetXpPsC7p_MS_fx68-O6yfbfv-2ut_vMcF7GTApKiKWWSl5yW4tWGF4D7-qqFK0pidXQUVII28q24HXLJJNQVLZknSjSe3GJsjX3l-7V7N2g_UlN2qlmu1ezDhEWrwjliRb1kSb-auVnP_1eIEQ1uGCg7_UI0xIUrVOoJBWpEspX1PgpBA_dcz4l6ixOHdQqTp3FKSJVEpfGPjw1LO0A9nnon6kEfF4BSHs5OvAqmLTq5Mt5MFHZyf2_4RGVO6tL</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Ouadani, Hanen</creator><creator>Ben-Mustapha, Imen</creator><creator>Ben-ali, Meriem</creator><creator>Larguèche, Beya</creator><creator>Jovanic, Tihana</creator><creator>Garcia, Sylvie</creator><creator>Arcangioli, Benoit</creator><creator>Elloumi-Zghal, Houda</creator><creator>Fathallah, Dahmani</creator><creator>Hachicha, Mongia</creator><creator>Masmoudi, Hatem</creator><creator>Rougeon, François</creator><creator>Barbouche, Mohamed-Ridha</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-0525-8620</orcidid><orcidid>https://orcid.org/0000-0002-1371-1405</orcidid><orcidid>https://orcid.org/0000-0002-7655-8911</orcidid></search><sort><creationdate>201611</creationdate><title>Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate</title><author>Ouadani, Hanen ; Ben-Mustapha, Imen ; Ben-ali, Meriem ; Larguèche, Beya ; Jovanic, Tihana ; Garcia, Sylvie ; Arcangioli, Benoit ; Elloumi-Zghal, Houda ; Fathallah, Dahmani ; Hachicha, Mongia ; Masmoudi, Hatem ; Rougeon, François ; Barbouche, Mohamed-Ridha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-95100d1d19464d85b5c48e4f8765bc60daef1035db9b348b2929e37d62f530353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Activation induced cytidine deaminase</topic><topic>AID mutagenic activity</topic><topic>Blotting, Western</topic><topic>Class switch recombination</topic><topic>Cofactors</topic><topic>Cytidine Deaminase</topic><topic>Cytidine Deaminase - genetics</topic><topic>Humans</topic><topic>Hyper IgM 2</topic><topic>Hyper-IgM Immunodeficiency Syndrome</topic><topic>Hyper-IgM Immunodeficiency Syndrome - genetics</topic><topic>Immunoglobulin Class Switching</topic><topic>Immunoglobulin Class Switching - genetics</topic><topic>Jurkat Cells</topic><topic>Life Sciences</topic><topic>Mutagenesis, Site-Directed</topic><topic>Mutation</topic><topic>Somatic hypermutation</topic><topic>Somatic Hypermutation, Immunoglobulin</topic><topic>Somatic Hypermutation, Immunoglobulin - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ouadani, Hanen</creatorcontrib><creatorcontrib>Ben-Mustapha, Imen</creatorcontrib><creatorcontrib>Ben-ali, Meriem</creatorcontrib><creatorcontrib>Larguèche, Beya</creatorcontrib><creatorcontrib>Jovanic, Tihana</creatorcontrib><creatorcontrib>Garcia, Sylvie</creatorcontrib><creatorcontrib>Arcangioli, Benoit</creatorcontrib><creatorcontrib>Elloumi-Zghal, Houda</creatorcontrib><creatorcontrib>Fathallah, Dahmani</creatorcontrib><creatorcontrib>Hachicha, Mongia</creatorcontrib><creatorcontrib>Masmoudi, Hatem</creatorcontrib><creatorcontrib>Rougeon, François</creatorcontrib><creatorcontrib>Barbouche, Mohamed-Ridha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Molecular immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ouadani, Hanen</au><au>Ben-Mustapha, Imen</au><au>Ben-ali, Meriem</au><au>Larguèche, Beya</au><au>Jovanic, Tihana</au><au>Garcia, Sylvie</au><au>Arcangioli, Benoit</au><au>Elloumi-Zghal, Houda</au><au>Fathallah, Dahmani</au><au>Hachicha, Mongia</au><au>Masmoudi, Hatem</au><au>Rougeon, François</au><au>Barbouche, Mohamed-Ridha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate</atitle><jtitle>Molecular immunology</jtitle><addtitle>Mol Immunol</addtitle><date>2016-11</date><risdate>2016</risdate><volume>79</volume><spage>77</spage><epage>82</epage><pages>77-82</pages><issn>0161-5890</issn><eissn>1872-9142</eissn><abstract>•Stable Jurkat cell line expressing AID-His130Pro was established.•Mutagenic activity of AID-His130Pro mutant was assessed on an artificial substrate.•AID-His130Pro retained a significant mutagenic activity.•The His130 residue is located in a region required for CSR but not for SHM.
Activation induced cytidine deaminase (AID) is an essential enzyme for class switch recombination (CSR) and somatic hypermutation (SHM) during secondary immune response. Mutations in the AICDA gene are responsible for Hyper IgM 2 syndrome where both CSR and SHM or only CSR are affected. Indeed, triggering either of the two mechanisms requires the DNA deamination activity of AID. Besides, different domains of AID may be differentially involved in CSR and SHM through their interaction with specific cofactors. Herein, we studied the AID-induced SHM activity of the AID-His130Pro mutant identified in a patient with Hyper IgM 2 syndrome. AID mutagenic activity was monitored by the reversion of nonsense mutations of the EGFP gene assessed by flow cytometry. We found that the His130Pro mutation, which affects CSR, preserves AID mutagenic activity. Indeed, the His130 residue is located in a putative specific CSR region in the APOBEC-like domain, known to involve CSR specific cofactors that probably play a major role in AID physiological activities.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27716525</pmid><doi>10.1016/j.molimm.2016.09.025</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0525-8620</orcidid><orcidid>https://orcid.org/0000-0002-1371-1405</orcidid><orcidid>https://orcid.org/0000-0002-7655-8911</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0161-5890 |
ispartof | Molecular immunology, 2016-11, Vol.79, p.77-82 |
issn | 0161-5890 1872-9142 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_pasteur_01453058v1 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Activation induced cytidine deaminase AID mutagenic activity Blotting, Western Class switch recombination Cofactors Cytidine Deaminase Cytidine Deaminase - genetics Humans Hyper IgM 2 Hyper-IgM Immunodeficiency Syndrome Hyper-IgM Immunodeficiency Syndrome - genetics Immunoglobulin Class Switching Immunoglobulin Class Switching - genetics Jurkat Cells Life Sciences Mutagenesis, Site-Directed Mutation Somatic hypermutation Somatic Hypermutation, Immunoglobulin Somatic Hypermutation, Immunoglobulin - genetics |
title | Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T10%3A46%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20induced%20cytidine%20deaminase%20mutant%20(AID-His130Pro)%20from%20Hyper%20IgM%202%20patient%20retained%20mutagenic%20activity%20on%20SHM%20artificial%20substrate&rft.jtitle=Molecular%20immunology&rft.au=Ouadani,%20Hanen&rft.date=2016-11&rft.volume=79&rft.spage=77&rft.epage=82&rft.pages=77-82&rft.issn=0161-5890&rft.eissn=1872-9142&rft_id=info:doi/10.1016/j.molimm.2016.09.025&rft_dat=%3Cproquest_hal_p%3E1835390707%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835390707&rft_id=info:pmid/27716525&rft_els_id=S0161589016302061&rfr_iscdi=true |